Researchers found that COVID-19 may accelerate biological processes linked to Alzheimer’s, showing changes in brain-related ...

Researchers have identified two biomarkers that can reveal how sensitive an individual is to pain, and may offer new approaches for treating pain... | Clinical And Molecular Dx ...

A possible solution to the diagnostic difficulties in TIA would be a serum biomarker that can reliably detect (transient) brain ischaemia in an early phase after symptom onset. This would enable a ...

The next steps would require further validation of these biomarkers and then they may be developed into new diagnostic tools. Three different machine learning models and artificial intelligence ...

Nearly seven million Americans live with Alzheimer’s disease, a progressive condition that destroys memory and other mental ...